{"transactions":[{"id":919014,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option - Right to Buy","published_at":"2026-02-04T21:10:02.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 2, 2026 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2026, subject to the reporting person's continued service on each such vesting date."}],"balance_after":650000,"derivative":{"exercise_price":10.72,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001193125-26-037572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526037572/ownership.xml","form_type":"4"}},{"id":1292785,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option - Right to Buy","published_at":"2025-01-28T21:15:11.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":582000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":582000,"derivative":{"exercise_price":4.16,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":582000},"source":{"system":"sec-edgar","filing":"0000950170-25-009816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025009816/ownership.xml","form_type":"4"}},{"id":1458122,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option - Right to Buy","published_at":"2024-07-08T12:00:03.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 12, 2023 and vested 25% on the first anniversary of the vesting commencement date of May 12, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":2280400,"derivative":{"exercise_price":3.27,"expiration_date":"2033-05-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-081949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024081949/ownership.xml","form_type":"4"}},{"id":1458121,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-08T12:00:03.000Z","date":"2024-07-03","kind":"exercise","planned":false,"acquired":true,"shares":150000,"price":3.27,"value":490500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock."}],"balance_after":193360,"source":{"system":"sec-edgar","filing":"0000950170-24-081949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024081949/ownership.xml","form_type":"4"}},{"id":1593864,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-05T21:15:17.000Z","date":"2024-03-04","kind":"purchase","planned":false,"acquired":true,"shares":43360,"price":11.3475,"value":492027.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.96 to $11.50, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":43360,"source":{"system":"sec-edgar","filing":"0000950170-24-025933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024025933/ownership.xml","form_type":"4"}},{"id":1885190,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T16:17:17.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-23-000029","document":"wf-form4_168452741659043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000029/wf-form4_168452741659043.xml","form_type":"4"}},{"id":1885189,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:17:17.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."}],"balance_after":3750,"source":{"system":"sec-edgar","filing":"0001169245-23-000029","document":"wf-form4_168452741659043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000029/wf-form4_168452741659043.xml","form_type":"4"}},{"id":2262222,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-20T16:45:23.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-22-000063","document":"wf-form4_165307950359150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000063/wf-form4_165307950359150.xml","form_type":"4"}},{"id":2262221,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-05-20T16:45:23.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":17500,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001169245-22-000063","document":"wf-form4_165307950359150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000063/wf-form4_165307950359150.xml","form_type":"4"}},{"id":2681307,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-06-04T18:14:28.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":14000,"derivative":{"exercise_price":3.53,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001169245-21-000064","document":"wf-form4_162284484859159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000064/wf-form4_162284484859159.xml","form_type":"4"}},{"id":3120773,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2020-06-05T18:39:40.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":4909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2021 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":4909,"derivative":{"exercise_price":4.86,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":4909},"source":{"system":"sec-edgar","filing":"0001169245-20-000057","document":"wf-form4_159139675921098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000057/wf-form4_159139675921098.xml","form_type":"4"}},{"id":3271016,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-14T18:50:28.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from February 12, 2020, subject to the reporting person's continued service through each such date."}],"balance_after":32000,"derivative":{"exercise_price":5.19,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001169245-20-000030","document":"wf-form4_158172421148134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000030/wf-form4_158172421148134.xml","form_type":"4"}},{"id":3843400,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-08-15T16:27:04.000Z","date":"2018-08-14","kind":"purchase","acquired":true,"shares":21700,"price":22.83,"value":495411.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.65 - 23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are owned directly by Alexander C. Sapir Revocable Trust (the \"Trust\").  The Reporting person is the trustee of the Trust."}],"balance_after":21700,"source":{"system":"sec-edgar","filing":"0001209191-18-046800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919118046800/doc4.xml","form_type":"4"}},{"id":4121010,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-27T16:32:41.000Z","date":"2017-12-22","kind":"exercise","acquired":false,"shares":26809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of Common Stock and shall vest over a period of four years as follows: (i) 25% of the total shares subject to the option shall vest on January 3, 2018, and (ii) 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":887291,"derivative":{"exercise_price":3.73,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":26809},"source":{"system":"sec-edgar","filing":"0001209191-17-067415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919117067415/doc4.xml","form_type":"4"}},{"id":4121009,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-12-27T16:32:41.000Z","date":"2017-12-22","kind":"exercise","acquired":true,"shares":26809,"price":3.73,"value":99997.57,"ownership":{"direct":true},"balance_after":46909,"source":{"system":"sec-edgar","filing":"0001209191-17-067415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919117067415/doc4.xml","form_type":"4"}},{"id":4260933,"issuer":{"id":153784,"kind":"organization","name":"Dova Pharmaceuticals Inc.","symbol":"DOVA"},"owners":[{"id":67709,"kind":"person","name":"Sapir Alex","position":1,"cik":"0001709415","reported_name":"Sapir Alex","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-07-07T06:44:20.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":20100,"price":17,"value":341700.0,"ownership":{"direct":true},"balance_after":20100,"source":{"system":"sec-edgar","filing":"0001209191-17-044261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685071/000120919117044261/doc4.xml","form_type":"4"}}]}